vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and KENNAMETAL INC (KMT). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $592.6M, roughly 1.3× KENNAMETAL INC). KENNAMETAL INC runs the higher net margin — 10.3% vs 3.6%, a 6.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 21.8%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 4.4%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Kennametal, Inc. is a manufacturer of high-performance cutting tools and engineered components used in the aerospace, defense, transportation and oil and gas drilling industries. Its customer base is global.
CLOV vs KMT — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $749.2M | $592.6M |
| Net Profit | $27.3M | $61.1M |
| Gross Margin | — | 35.1% |
| Operating Margin | 3.6% | 13.4% |
| Net Margin | 3.6% | 10.3% |
| Revenue YoY | 62.0% | 21.8% |
| Net Profit YoY | — | 85.0% |
| EPS (diluted) | $0.05 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $749.2M | $592.6M | ||
| Q4 25 | $487.7M | $529.5M | ||
| Q3 25 | $496.6M | $498.0M | ||
| Q2 25 | $477.6M | $516.4M | ||
| Q1 25 | $462.3M | $486.4M | ||
| Q4 24 | $337.0M | $482.1M | ||
| Q3 24 | $331.0M | $481.9M | ||
| Q2 24 | $356.3M | $543.3M |
| Q1 26 | $27.3M | $61.1M | ||
| Q4 25 | $-49.3M | $33.9M | ||
| Q3 25 | $-24.4M | $23.3M | ||
| Q2 25 | $-10.6M | $21.6M | ||
| Q1 25 | $-1.3M | $31.5M | ||
| Q4 24 | $-22.1M | $17.9M | ||
| Q3 24 | $-9.2M | $22.1M | ||
| Q2 24 | $7.4M | $37.2M |
| Q1 26 | — | 35.1% | ||
| Q4 25 | — | 32.8% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | — | 28.2% | ||
| Q1 25 | — | 32.1% | ||
| Q4 24 | — | 30.1% | ||
| Q3 24 | 24.5% | 31.3% | ||
| Q2 24 | 30.3% | 31.5% |
| Q1 26 | 3.6% | 13.4% | ||
| Q4 25 | -10.1% | 9.9% | ||
| Q3 25 | -4.9% | 7.5% | ||
| Q2 25 | -2.2% | 6.1% | ||
| Q1 25 | -0.3% | 9.1% | ||
| Q4 24 | -6.4% | 6.6% | ||
| Q3 24 | -2.7% | 7.5% | ||
| Q2 24 | 2.0% | 11.3% |
| Q1 26 | 3.6% | 10.3% | ||
| Q4 25 | -10.1% | 6.4% | ||
| Q3 25 | -4.9% | 4.7% | ||
| Q2 25 | -2.2% | 4.2% | ||
| Q1 25 | -0.3% | 6.5% | ||
| Q4 24 | -6.6% | 3.7% | ||
| Q3 24 | -2.8% | 4.6% | ||
| Q2 24 | 2.1% | 6.8% |
| Q1 26 | $0.05 | $0.75 | ||
| Q4 25 | — | $0.44 | ||
| Q3 25 | — | $0.30 | ||
| Q2 25 | — | $0.28 | ||
| Q1 25 | — | $0.41 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | — | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.6M | $106.8M |
| Total DebtLower is stronger | — | $597.4M |
| Stockholders' EquityBook value | $339.4M | — |
| Total Assets | $697.7M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $177.6M | $106.8M | ||
| Q4 25 | $78.3M | $129.3M | ||
| Q3 25 | — | $103.5M | ||
| Q2 25 | — | $140.5M | ||
| Q1 25 | — | $97.5M | ||
| Q4 24 | $194.5M | $121.2M | ||
| Q3 24 | $288.0M | $119.6M | ||
| Q2 24 | $254.8M | $128.0M |
| Q1 26 | — | $597.4M | ||
| Q4 25 | — | $597.2M | ||
| Q3 25 | — | $597.0M | ||
| Q2 25 | — | $596.8M | ||
| Q1 25 | — | $596.6M | ||
| Q4 24 | — | $596.4M | ||
| Q3 24 | — | $596.2M | ||
| Q2 24 | — | $596.0M |
| Q1 26 | $339.4M | — | ||
| Q4 25 | $308.7M | $1.3B | ||
| Q3 25 | $340.9M | $1.3B | ||
| Q2 25 | $344.2M | $1.3B | ||
| Q1 25 | $336.1M | $1.2B | ||
| Q4 24 | $341.1M | $1.2B | ||
| Q3 24 | $342.2M | $1.3B | ||
| Q2 24 | $324.9M | $1.2B |
| Q1 26 | $697.7M | $2.7B | ||
| Q4 25 | $541.0M | $2.6B | ||
| Q3 25 | $559.7M | $2.5B | ||
| Q2 25 | $575.0M | $2.5B | ||
| Q1 25 | $583.7M | $2.5B | ||
| Q4 24 | $580.7M | $2.4B | ||
| Q3 24 | $653.0M | $2.5B | ||
| Q2 24 | $674.2M | $2.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.46× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.49× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
KMT
| Americas | $298.3M | 50% |
| EMEA | $174.0M | 29% |
| Asia Pacific | $120.3M | 20% |
